Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2023; doi:10.1038/s41391-023-00680-4Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2023 Category: Urology & Nephrology Authors: Martin W. Schoen Kenneth R. Carson Seth A. Eisen Charles L. Bennett Suhong Luo Melissa A. Reimers Eric M. Knoche Alison L. Whitmer Yan Yan Bettina F. Drake Kristen M. Sanfilippo Source Type: research

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2023; doi:10.1038/s41391-023-00682-2Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2023 Category: Urology & Nephrology Authors: Carsten-Henning Ohlmann Michelle J äschke Peter Jaehnig Susanne Krege J ürgen Gschwend Heidrun Rexer Kerstin Junker Roger Zillmann Christoph R üssel Eva Hellmis Henrik Suttmann Martin Janssen Jan Marin Andreas H übner Michael Mathers Jochen Glei ßner Source Type: research

Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 27 May 2023; doi:10.1038/s41391-023-00678-yFunctional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 27, 2023 Category: Urology & Nephrology Authors: Massimiliano Creta Celeste Manfredi Davide Arcaniolo Lorenzo Spirito Steven A. Kaplan Henry H. Woo Cosimo De Nunzio Peter Gilling Thorsten Bach Marco De Sio Ciro Imbimbo Vincenzo Mirone Nicola Longo Ferdinando Fusco Source Type: research

Guidelines for genetic testing in prostate cancer: a scoping review
Prostate Cancer and Prostatic Diseases, Published online: 18 May 2023; doi:10.1038/s41391-023-00676-0Guidelines for genetic testing in prostate cancer: a scoping review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 18, 2023 Category: Urology & Nephrology Authors: Haitham Tuffaha Kim Edmunds David Fairbairn Matthew J. Roberts Suzanne Chambers David P. Smith Lisa Horvath Shiksha Arora Paul Scuffham Source Type: research

Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 16 May 2023; doi:10.1038/s41391-023-00677-zEnucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 16, 2023 Category: Urology & Nephrology Authors: Nikolaos Pyrgidis Ioannis Mykoniatis Lukas Lusuardi Gerald Bastian Schulz Ioannis Sokolakis Christian Stief Petros Sountoulides Source Type: research

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis
Prostate Cancer and Prostatic Diseases, Published online: 16 May 2023; doi:10.1038/s41391-023-00675-1ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 16, 2023 Category: Urology & Nephrology Authors: Ronald Tutrone Ben Lowentritt Brian Neuman Michael J. Donovan Elliot Hallmark T. Jeffrey Cole Yiyuan Yao Claire Biesecker Sonia Kumar Vinita Verma Grannum R. Sant Jason Alter Johan Skog Source Type: research

PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 05 May 2023; doi:10.1038/s41391-023-00666-2PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 5, 2023 Category: Urology & Nephrology Authors: Tahlia Scheinberg Hui-Ming Lin Michael Fitzpatrick Arun A. Azad Paul Bonnitcha Amy Davies Gillian Heller Kevin Huynh Blossom Mak Kate Mahon David Sullivan Peter J. Meikle Lisa G. Horvath Source Type: research

15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 04 May 2023; doi:10.1038/s41391-023-00674-215-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 4, 2023 Category: Urology & Nephrology Authors: Akshay Sood Ralph Grauer Mireya Diaz-Insua Ashutosh K. Tewari Ashok K. Hemal Alok Shrivastava James O. Peabody Wooju Jeong Firas Abdollah Jan K. Rudzinski Jack R. Andrews Michael A. Gorin Mahendra Bhandari Mani Menon Source Type: research

Disparities in prostate cancer diagnosis and management: recognizing that disparities exist at all junctures along the prostate cancer journey
Prostate Cancer and Prostatic Diseases, Published online: 28 April 2023; doi:10.1038/s41391-023-00665-3Disparities in prostate cancer diagnosis and management: recognizing that disparities exist at all junctures along the prostate cancer journey (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 28, 2023 Category: Urology & Nephrology Authors: Soroush Rais-Bahrami Yao Zhu Source Type: research

A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading
Prostate Cancer and Prostatic Diseases, Published online: 25 April 2023; doi:10.1038/s41391-023-00673-3A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 25, 2023 Category: Urology & Nephrology Authors: Andrey Morozov Mark Taratkin Andrey Bazarkin Juan Gomez Rivas Stefano Puliatti Enrico Checcucci Ines Rivero Belenchon Karl-Friedrich Kowalewski Anastasia Shpikina Nirmish Singla Jeremy Y. C. Teoh Vasiliy Kozlov Severin Rodler Pietro Piazza Harun Fajkovic Source Type: research

Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?
Prostate Cancer and Prostatic Diseases, Published online: 22 April 2023; doi:10.1038/s41391-023-00671-5Relationship between cigarette use and prostate cancer risk: what do we know and what should we do? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 22, 2023 Category: Urology & Nephrology Authors: Jos é Ignacio Nolazco Lorelei A. Mucci Roman Sosnowski Krzysztof Przewo źniak Steven L. Chang Cosimo De Nunzio Source Type: research

The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery
Prostate Cancer and Prostatic Diseases, Published online: 21 April 2023; doi:10.1038/s41391-023-00672-4The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 21, 2023 Category: Urology & Nephrology Authors: Andrea Fuschi Antonio Luigi Pastore Yazan Al Salhi Alessia Martoccia Cosimo De Nunzio Giorgia Tema Onofrio Antonio Rera Flavia Carbone Anastasios D. Asimakopoulos Manfredi Bruno Sequi Fabio Maria Valenzi Paolo Pietro Suraci Silvio Scalzo Francesco Del Giu Source Type: research

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation
Prostate Cancer and Prostatic Diseases, Published online: 20 April 2023; doi:10.1038/s41391-023-00669-zAblative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 20, 2023 Category: Urology & Nephrology Authors: David-Dan Nguyen Tiange Li Roseanne Ferreira Mohamad Baker Berjaoui Anna-Lisa V. Nguyen Bilal Chughtai Kevin C. Zorn Naeem Bhojani Dean Elterman Source Type: research

Radiotheranostics in advanced prostate cancer: Current and future directions
Prostate Cancer and Prostatic Diseases, Published online: 14 April 2023; doi:10.1038/s41391-023-00670-6Radiotheranostics in advanced prostate cancer: Current and future directions (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 14, 2023 Category: Urology & Nephrology Authors: Angela Y. Jia Ana P. Kiess Qiubai Li Emmanuel S. Antonarakis Source Type: research

Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy
Prostate Cancer and Prostatic Diseases, Published online: 13 April 2023; doi:10.1038/s41391-023-00668-0Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 13, 2023 Category: Urology & Nephrology Authors: Luca Afferi Mattia Longoni Marco Moschini Giorgio Gandaglia Alicia K. Morgans Richard Cathomas Agostino Mattei Alberto Breda Roberto Mario Scarpa Rocco Papalia Cosimo de Nunzio Francesco Esperto Source Type: research